Showing results (1571-1580 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|December 18, 2001
Estimation of absorption rate of alpha-human atrial natriuretic peptide from the plasma profile and diuretic effect after intranasal administration to ratsM Miyamoto, T Tsukune, S Hori, et al.Biopharmaceutics & Drug Disposition|September 16, 1998
Uptake of verteporfin by articular tissues following systemic and intra-articular administrationR K Chowdhary, L G Ratkay, A J Canaan, et al.Biopharmaceutics & Drug Disposition|April 17, 1999
Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemiaH Yamada, H Kotaki, H Furitsu, et al.Biopharmaceutics & Drug Disposition|July 30, 2009
Mechanisms responsible for the altered pharmacokinetics of bosentan: analysis utilizing rats with bile duct ligation-induced liver dysfunctionIsao Horiuchi, Yun-I Mori, Masato Taguchi, et al.Biopharmaceutics & Drug Disposition|February 20, 2009
Biliary clearance of bromosulfophthalein in anesthetized and freely moving conscious ratJu-Hee Oh, Se-Eun Park, Chang-Koo Shim, et al.Biopharmaceutics & Drug Disposition|August 21, 2001
Theoretical pharmacokinetic and pharmacodynamic simulations of drug delivery mediated by blood--brain barrier transportersK M Mahar Doan, K M BojeBiopharmaceutics & Drug Disposition|August 21, 2001
Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in ratsH J Kim, S H Kim, S O Kim, et al.Biopharmaceutics & Drug Disposition|August 28, 2001
Pharmacokinetic assessment of an oral enalapril suspension for use in childrenR K Rippley, J Connor, J Boyle, et al.Biopharmaceutics & Drug Disposition|August 28, 2001
Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymesL H Cohen, R E van Leeuwen, G C van Thiel, et al.Biopharmaceutics & Drug Disposition|August 28, 2001
Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drugD R BrocksPageof 214